On May 11, 2023, the U.S. government announced the end of the formal Public Health Emergency (PHE) related to the COVID-19 pandemic. This end to the national emergency triggered several changes impacting COVID-19 testing, as well as changes to requirements of health insurers that may impact the broader use of telehealth services in some states. However, the end of the Public Health Emergency did not change the FDA approval or authorization status of tests, vaccines, and treatments related to COVID-19.

This toolkit, a joint effort between the U.S. Conference of Mayors and Pfizer, was designed to help mayors communicate the importance of continued COVID-19 testing and treatment following the formal end of the PHE, particularly as schools are back in session and as we head into cold and flu season.

For more information, please contact Crystal Swann.